<DOC>
	<DOCNO>NCT01551940</DOCNO>
	<brief_summary>Evaluation decrease secretion saliva patient amyotrophic lateral sclerosis local ultrasound-guided bilateral injection botulinum toxin type A parotids submandibular gland . The investigator want demonstrate 1 month injection , multicenter French randomize double blind study , improvement least 25 % functional embarrassment due saliva , estimate visual analogue scale , decrease quantity saliva decrease embarrassment main caregiver .</brief_summary>
	<brief_title>Toxin Treatment Amyotrophic Lateral Sclerosis ( ALS ) Related Sialorrhea</brief_title>
	<detailed_description>The patient benefit ultrasound guide injection botulinum toxin A ( BotoxÂ® ) placebo ( NaCl 0.9 % ) follow consultation 4 , 12 , 16 ( reinjection ) 24 week . He contact telephone 2 8 week ( percentage decrease functional embarrassment , percentage decrease salivary secretion rate ) . He able benefit open label phase botulinum toxin type A injection 12-week follow estimate first injection effective efficiency first injection begin become blur . After 6 month study , patient benefit usual follow-up advise French consensus conference November , 2005 .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Sialorrhea</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Age &gt; 18 year Obtaining write consent information Diagnosis probable certain ALS accord El Escorial criterion World Federation Neurology Committee Neuromuscular Diseases Patient followup ALS center Sialorrhea VAS functional embarrassment &gt; equal 50/100 . Patient beneficiary Social Security regime Evolving disease associate predictable survival &lt; 1 month Patient previously receive injection botulinum toxin salivary gland Patient take medical treatment sialorrhea 7 day inclusion study ( scopoderm , trihexyph'nidyle , atropine , ipatropium , amitriptyline , clomipramine , oxybutinine , diphenhydramine , betablockers ) Patient benefit radiotherapy surgery salivary gland Behavioral problem , dementia psychiatric problem Myasthenia Known Pregnancy absence contraception recognize effective , breast feed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Sialorrhea</keyword>
	<keyword>Amyotrophic lateral sclerosis</keyword>
	<keyword>Botulinum toxin</keyword>
</DOC>